Compounds > alpha-methyl-4-carboxyphenylglycine

alpha-methyl-4-carboxyphenylglycine and Nerve Degeneration

alpha-methyl-4-carboxyphenylglycine has been researched along with Nerve Degeneration in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ding, S; Li, H; Sun, G; Zhang, N1
Croucher, MJ; Datla, KP; Dexter, DT; Vernon, AC; Zbarsky, V1
Battaglia, G; Bruno, V; Copani, A; Leanza, G; Nicoletti, F; Pellitteri, R; Russo, A; Stanzani, S1
Battaglia, G; Bond, A; Bruno, V; Clark, BP; Harris, JR; Kingston, AE; Lodge, D; Monn, JA; Nicoletti, F; O'Neill, MJ; Schoepp, DD1
Benarese, M; Boroni, F; Goffi, F; Pizzi, M; Spano, PF; Valerio, A1

Other Studies

5 other study(ies) available for alpha-methyl-4-carboxyphenylglycine and Nerve Degeneration

ArticleYear
Inhibition of the group I mGluRs reduces acute brain damage and improves long-term histological outcomes after photothrombosis-induced ischaemia.
    ASN neuro, 2013, Jul-11, Volume: 5, Issue:3

    Topics: Animals; Antimetabolites, Antineoplastic; Astrocytes; Benzoates; Blotting, Western; Brain; Brain Ischemia; Bromodeoxyuridine; Cell Death; Cell Proliferation; Cerebral Infarction; Excitatory Amino Acid Antagonists; Glycine; Immunohistochemistry; In Situ Nick-End Labeling; Intracranial Thrombosis; Male; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neuroglia; Pyridines; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate

2013
Subtype selective antagonism of substantia nigra pars compacta Group I metabotropic glutamate receptors protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo.
    Journal of neurochemistry, 2007, Volume: 103, Issue:3

    Topics: Animals; Benzoates; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Glutamic Acid; Glycine; Male; Molecular Structure; Nerve Degeneration; Neural Pathways; Neuroprotective Agents; Neurotoxins; Oxidopamine; Parkinsonian Disorders; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Substantia Nigra; Treatment Outcome; Tyrosine 3-Monooxygenase

2007
Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide.
    Molecular pharmacology, 1995, Volume: 47, Issue:5

    Topics: Aminobutyrates; Amyloid beta-Peptides; Animals; Apoptosis; Benzoates; Calcium Channels; Cells, Cultured; Cerebellum; Cycloleucine; Glycine; Mice; Nerve Degeneration; Neurons; Peptide Fragments; Phosphoserine; Receptors, Metabotropic Glutamate

1995
Neuroprotective actions of novel and potent ligands of group I and group II metabotropic glutamate receptors.
    Annals of the New York Academy of Sciences, 1999, Volume: 890

    Topics: Animals; Benzoates; Bridged Bicyclo Compounds; Cells, Cultured; Cerebral Cortex; Drug Evaluation, Preclinical; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Gerbillinae; Glycine; Ischemia; Male; N-Methylaspartate; Nerve Degeneration; Neurons; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Thiophenes

1999
Neuroprotection by metabotropic glutamate receptor agonists on kainate-induced degeneration of motor neurons in spinal cord slices from adult rat.
    Neuropharmacology, 2000, Mar-03, Volume: 39, Issue:5

    Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Benzoates; Cell Survival; Choline O-Acetyltransferase; Cycloleucine; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glycine; In Situ Nick-End Labeling; In Vitro Techniques; Kainic Acid; Male; Motor Neurons; N-Methylaspartate; Nerve Degeneration; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Spinal Cord

2000